Clinical trials
Prostatic Hyperplasia trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 13 |
| 2015 | 7 |
| 2016 | 4 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Unknown status | 11 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Samsung Medical Center | 11 |
| Chong Kun Dang Pharmaceutical | 7 |
| Seoul National University Hospital | 5 |
| Addpharma Inc. | 4 |
| GlaxoSmithKline | 4 |
| Hanmi Pharmaceutical Company Limited | 4 |
| JW Pharmaceutical | 4 |
| Dongkook Pharmaceutical Co., Ltd. | 3 |
| Allergan | 2 |
| DongGuk University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 69 |
| Lower Urinary Tract Symptoms | 7 |
| Urinary Bladder, Overactive | 5 |
| Erectile Dysfunction | 3 |
| Prostatic Neoplasms | 2 |
| Kidney Failure, Chronic | 1 |
| Nocturia | 1 |
| Pyuria | 1 |
| Urinary Bladder Neck Obstruction | 1 |
| Urinary Bladder Neoplasms | 1 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.